You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BCAX Exercise Disclosure
Mazumdar Claire · SEC Form 4 · Filed Aug 12, 2026
Exercise
Calculated transaction value
$37.9K
Mazumdar Claire Chief Executive Officer
BCAX
Transaction date
Aug 10, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 2 days later
BCAX daily price context
Close on/before transaction
$27.73
Aug 10, 2026
First close after public filing
$23.63
Aug 13, 2026
30-day return after filing
-3.47%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,000 shares @ $3.79
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001470831-26-000813
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$317.65K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bicara Therapeutics Inc. BCAX | Exercise | Aug 10, 2026 | $0 |
| Bicara Therapeutics Inc. BCAX Current | Exercise | Aug 10, 2026 | $37.9K |
| Bicara Therapeutics Inc. BCAX | Sale | Aug 10, 2026 | $279.75K |